These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6086470)

  • 21. A geographical study of antibodies to membrane antigens of HSV-2-infected cells and HSV-2-specific antibodies in patients with cervical cancer.
    Mendis LN; Best JM; Senarath L; Chiphangwi J; Vestergaard BF; Banatvala JE
    Int J Cancer; 1981 Nov; 28(5):535-42. PubMed ID: 6273337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to the herpes simplex virus type-2-induced tumor-associated antigen AG-4 as markers of recurrence in cervical cancer.
    te Velde ER; Aurelian L
    Tumour Biol; 1987; 8(1):26-33. PubMed ID: 3037680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herpes simplex virus type 2 and human cervical cancer: relationship between cellular and immune assays for the detection of previous infection.
    Smith JW; Torres JE; Holmquist ND
    J Natl Cancer Inst; 1981 Jun; 66(6):1031-6. PubMed ID: 6941038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of type 2 herpes simplex virus induced cervical carcinoma in mice by prior immunization with a vaccine prepared from type 1 herpes simplex virus.
    Chen MH; Dong CY; Liu ZH; Skinner GR; Hartley CE
    Vaccine; 1983 Dec; 1(1):13-6. PubMed ID: 6099637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody to herpes simplex virus type 2-induced nonstructural proteins in women with cervical cancer and in control groups.
    Anzai T; Dreesman GR; Courtney RJ; Adam E; Rawls WE; Benyesh-Melnick M
    J Natl Cancer Inst; 1975 May; 54(5):1051-9. PubMed ID: 165303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutralising antibody against type 1 and type 2 herpes simplex virus in cervical mucus of women with cervical intra-epithelial neoplasia.
    Murphy JF; Murphy DF; Barker S; Mylotte ML; Coughlan BM; Skinner GR
    Med Microbiol Immunol; 1985; 174(2):73-80. PubMed ID: 2993833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection with herpes-simplex viruses 1 and 2. II.
    Nahmias AJ; Roizman B
    N Engl J Med; 1973 Oct; 289(14):719-25. PubMed ID: 4353782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgG-, IgA- and IgM-antibodies to herpes simplex virus type 2 in sera from patients with cancer of the uterine cervix.
    El Falaky IH; Vestergaard BF
    Eur J Cancer (1965); 1977 Mar; 13(3):247-51. PubMed ID: 193693
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum antibodies to herpesvirus early antigens in patients with cervical carcinoma determined by anticomplement immunofluorescence technique.
    Ito H; Tsutsui F; Kurihara S; Akabayashi T; Tobe T
    Int J Cancer; 1976 Nov; 18(5):557-63. PubMed ID: 62718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Herpes simplex virus type 2 antibodies in the husbans of women with cervical cancer].
    Kunkel M; Oberender H; Rätz KH; Hofmann R; Gärtner L; Heise H
    Z Gesamte Hyg; 1979 Aug; 25(8):597-9. PubMed ID: 228506
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibodies to Herpes simplex virus in Jewish women with cervical cancer and in healthy Jewish women of Israel.
    Menczer J; Leventon-Kriss S; Modan M; Oelsner G; Gerichter CB
    J Natl Cancer Inst; 1975 Jul; 55(1):3-6. PubMed ID: 169365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Class-specific herpes simplex virus antibodies in sera and cervical secretions from patients with cervical neoplasia: a multi-group comparison.
    Dale GE; Coleman RM; Best JM; Benetato BB; Drew NC; Chinn S; Papacosta AO; Nahmias AJ
    Epidemiol Infect; 1988 Jun; 100(3):445-65. PubMed ID: 2837405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of antibodies to herpesvirus types 1 and 2 in human sera by microradioimmunoassay.
    Jankowski MA; Petersen EE; Böcker JF
    Acta Virol; 1977 Sep; 21(5):405-11. PubMed ID: 22235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of herpes simplex type 2 virus with cervical cancer of the uterus.
    Kao CL; Chen YH; Tang MC; Wen HK; Hsia S
    Taiwan Yi Xue Hui Za Zhi; 1974 Feb; 73(2):122-7. PubMed ID: 4368434
    [No Abstract]   [Full Text] [Related]  

  • 35. [Seroepidemiological studies related to the association of genital herpes to cervical cancer (author's transl)].
    Koenig UD; Haag A; Lehmk
    Geburtshilfe Frauenheilkd; 1975 Dec; 35(12):909-13. PubMed ID: 174969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific non-immunoglobulin G antibodies and cell-mediated response to herpes simplex virus antigens in women with cervical carcinoma.
    Thiry L; Sprecher-Goldberger S; Hannecart-Pokorni E; Gould I; Bossens M
    Cancer Res; 1977 May; 37(5):1301-6. PubMed ID: 192446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlamydia trachomatis and herpes simplex virus IgA antibodies in cervical secretions of patients with cervical atypia.
    Kalimo K; Terho P; Honkonen E; Grönroos M; Halonen P
    Br J Obstet Gynaecol; 1981 Nov; 88(11):1130-4. PubMed ID: 6271164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement-dependent cytotoxic antibodies in the course of cervical carcinoma.
    Christenson B
    Int J Cancer; 1977 Nov; 20(5):694-701. PubMed ID: 200570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes simplex virus antibody in south Indian patients with carcinoma cervix.
    Seshadri L; Seth P; Walter A; Seshadri MS; John TJ
    Indian J Med Res; 1984 Jan; 79():13-8. PubMed ID: 6327511
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevalence of type-specific antibody against type 1 and type 2 herpes simplex virus in women with abnormal cervical cytology: evidence towards pre-pubertal vaccination of sero-negative female subjects.
    Skinner GR; Whitney JE; Hartley C
    Arch Virol; 1977; 54(3):211-21. PubMed ID: 196578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.